NorthStar to suspend production of Mo-99 radioisotopes

NorthStar Medical Radioisotopes, LLC will suspend manufacturing and commercialization of molybdenum-99 (Mo-99) by the end of 2023, the company announced Thursday.

Related Keywords

,Contract Development ,Northstar Medical Radioisotopes ,Star Therapeutics ,Manufacturing Operations ,Radioisotopes ,